XETRA - Delayed Quote EUR

LIMES Schlosskliniken AG (LIK.DE)

270.00
-10.00
(-3.57%)
As of 2:17:36 PM GMT+2. Market Open.
Loading Chart for LIK.DE
  • Previous Close 280.00
  • Open 280.00
  • Bid 266.00 x --
  • Ask 274.00 x --
  • Day's Range 266.00 - 280.00
  • 52 Week Range 250.00 - 390.00
  • Volume 57
  • Avg. Volume 38
  • Market Cap (intraday) 79.162M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) 18.51
  • EPS (TTM) 14.59
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein. It focuses on the treatment of stress-related illnesses, and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, burnout, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was formerly known as GMF Capital AG and changed its name to LIMES Schlosskliniken AG in December 2005. The company was founded in 2005 and is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of G M F Capital GmbH.

www.limes-schlosskliniken.de

210

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LIK.DE

View More

Performance Overview: LIK.DE

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

LIK.DE
18.18%
DAX P (^GDAXI)
18.12%

1-Year Return

LIK.DE
18.67%
DAX P (^GDAXI)
25.27%

3-Year Return

LIK.DE
8.00%
DAX P (^GDAXI)
71.16%

5-Year Return

LIK.DE
200.00%
DAX P (^GDAXI)
117.35%

Compare To: LIK.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LIK.DE

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    81.51M

  • Enterprise Value

    82.35M

  • Trailing P/E

    19.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.96

  • Price/Book (mrq)

    4.88

  • Enterprise Value/Revenue

    1.97

  • Enterprise Value/EBITDA

    55.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.23%

  • Return on Assets (ttm)

    11.34%

  • Return on Equity (ttm)

    27.91%

  • Revenue (ttm)

    41.78M

  • Net Income Avi to Common (ttm)

    4.27M

  • Diluted EPS (ttm)

    14.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.83M

  • Total Debt/Equity (mrq)

    47.31%

  • Levered Free Cash Flow (ttm)

    -1.7M

Research Analysis: LIK.DE

View More

People Also Watch